Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
benzodiazepine
sedative anticonvulsant |
| gptkbp:alsoKnownAs |
Mebaral
mephobarbital |
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
N03AA03
|
| gptkbp:CASNumber |
115-38-8
|
| gptkbp:chemicalFormula |
C13H14N2O3
|
| gptkbp:hasSMILES |
CC[C@]1(C2=CC=CC=C2)NC(=O)NC(=O)C1C
|
| https://www.w3.org/2000/01/rdf-schema#label |
methylphenobarbital
|
| gptkbp:isDiscontinuedIn |
gptkb:United_States
|
| gptkbp:isMetabolizedTo |
phenobarbital
|
| gptkbp:isSchedule |
Schedule IV (US)
|
| gptkbp:IUPACName |
5-ethyl-1-methyl-5-phenylbarbituric acid
|
| gptkbp:molecularWeight |
246.26 g/mol
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:PubChem_CID |
6476
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
dizziness headache drowsiness |
| gptkbp:usedFor |
sedation
treatment of epilepsy |
| gptkbp:wasSynthesizedIn |
1930
|
| gptkbp:bfsParent |
gptkb:Phenobarbital
gptkb:N03AF_group |
| gptkbp:bfsLayer |
7
|